Protocol Ledger

NCT03579602 · Phase II/III · COMPLETED

Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Interventional Phase II/III clinical trial protocol NCT03579602 sponsored by Blaze Bioscience in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-11-26 Enrollment: 118 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03579602
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)118 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03579602
Protocol FieldVerified Registry Value
NCT IdentifierNCT03579602
Consolidated Lead SponsorBlaze Bioscience
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II/III
Overall Recruitment StatusCOMPLETED
Registered Enrollment118 participants (ACTUAL)
Registered Start Date2018-11-26
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI